Last reviewed · How we verify
NCT05659004
Referrals for CLTI: Qualitative Study
trial testing Qualitative interview in Chronic Limb Threatening Ischemia in 20 participants. Completed in 7 July 2023.
7 July 2023
Quick facts
| Lead sponsor | University of Hull |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 20 |
| Start date | 10 January 2023 |
| Primary completion | 7 July 2023 |
| Estimated completion | 7 July 2023 |
| Sites | 2 locations across United Kingdom |
Drugs / interventions tested
- Qualitative interview
Conditions studied
- Chronic Limb Threatening Ischemia — all drugs for Chronic Limb Threatening Ischemia →
Sponsor
University of Hull
Who can join
Adults 18 to 120, any sex, with Chronic Limb Threatening Ischemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this qualitative study is to explore the experiences of patients who have been diagnosed with chronic limb-threatening ischaemia (CLTI). The main questions it aims to answer are: * What are the perceptions and experiences of patients between first symptom of CLTI and vascular surgery assessment * What is important to patients during this process. Participants will be interviewed and their words analysed using reflexive thematic analysis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05659004
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Qualitative interview
Trials testing the same drug.
- NCT07499934 — Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study · NA · recruiting
- NCT06815120 — A Novel Ureteric Stent in Kidney Stone Patients and Oncology Patients Compared to a Conventional JJ Stent · NA · not yet recruiting
- NCT06357845 — Linking Somatic Mutation Rate With Baseline Exposure in East Palestine · NA · recruiting
- NCT06330350 — Qualitative Study in Patients With Genodermatoses and Healthcare Professionals on Reproductive Counselling · recruiting
- NCT05887271 — A Randomised, Controlled Trial of a Low-energy Diet for Improving Functional Status in Heart Failure With PRESERVED Ejec · Phase 2, PHASE3 · recruiting
Other recruiting trials for Chronic Limb Threatening Ischemia
Currently open trials in the same condition.
- NCT07068789 — Revascularization of Single Vesrus Multiple Infrapopliteal Vessels in Chronic Limb Threatening Ischemia · NA · recruiting
- NCT05786001 — Multimodal Noninvasive Assessment of Peripheral Circulation in Chronic Limb-threatening Ischemia · recruiting
- NCT05553509 — Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity · active not recruiting
- NCT05620095 — Durg Coated Balloon Angioplasty in Infrapopliteal Lesions · recruiting
Other University of Hull trials
Trials by the same sponsor.
- NCT05646199 — Semaglutide vs Metformin in Polycystic Ovary Syndrome (PCOS) · Phase 2, PHASE3 · not yet recruiting
- NCT06276686 — Exercise for Improving Long-course Chemoradiotherapy Efficacy in People With Locally Advanced Rectal Cancer · EARLY_PHASE1 · recruiting
- NCT07299682 — Facilitating Effective Eating With DoddleBags: A Single-Arm Acceptability Study Of DoddleBags to Assess Impact on Self F · NA · recruiting
- NCT07376694 — Improving Uptake of Bowel Cancer Screening Among South Asian Adults in Bradford · NA · active not recruiting
- NCT06595316 — Exercise for Ameliorating Chemotherapy Cardiotoxicity · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05659004 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Hull
- Last refreshed: 24 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05659004.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing